Biologics

Philadelphia-based University of Pennsylvania Health system researchers at the McKay Orthopaedic Research Laboratory are developing new tissue engineering approaches to improve treatment for meniscus tears, the most common form of orthopedic surgery.

Roger Hartl, MD, director of spinal surgery and neurotrauma at Weill Cornell Brain and Spine Center in New York City and director of the Weill Cornell Medicine Center for Comprehensive Spine Care, offers two key thoughts on where spine surgery…

Michael Gordon, MD, a spine surgeon with Hoag Orthopedic Institute in Irvine, Calif., weighs in on trends he sees with regard to the use of spinal biologics.

Shelton, Conn.-based Spine Wave launched the GraftMag Graft Delivery System.

Surgeons have implanted 50 Bone Solutions' OsteoCrete.

Technavio analysts identified the top three trends of the global spinal biologics market between 2018 and 2022.

Cellular Biomedicine Group partnered with GE Healthcare to accelerate its stem cell therapy manufacturing timeline.

Former North American Spine Society President William Watters, MD, of Houston Medical, discusses the biggest spine technology, clinical and business trends for 2018.

The FDA granted clearance for Mayo Clinic Center for Regenerative Medicine in Jacksonville, Fla., to treat patients with its stem cell production platform, according to The Florida Times-Union.

The FDA cleared ORTHOReBIRTH USA's ReBOSSIS. ORTHOReBIRTH develops orthopedic biologics.